Western blot analysis confirmed that combined treatment significantly reduced the expression levels of RAGE, p-STAT3, STAT3, p-AKT, and PCNA in tumor tissues compared to the PT or CQ monotherapy groups (Figure 6B). This evidence concerns the gene STAT3 and neoplasm.